Skip to main content
Sister Publication Links
  • ModernHealthcare.com
Subscribe
  • My Account
  • Login
  • Register
  • Consumer Centric
  • Provider/Payer Centric
  • Funding/M&A
  • Policy
  • Data
  • Opinion
  • MORE+
    • Webinars
    • Advertise
MENU
Breadcrumb
  1. Home
  2. Technology
February 09, 2022 06:00 AM

Northwestern technology spinout lands $10 million

Crain's Chicago Business
John Pletz
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Epicore_Gx2.jpg

    Epicore Biosystems, a wearable-technology company spun out of Northwestern University, has raised $10 million in venture funding.

    Epicore is commercializing technology developed by a team led by John Rogers, one of Northwestern’s most prolific inventors. The technology captures sweat, which can be analyzed to monitor the health of athletes or workers by measuring how much fluid and electrolytes they’re using.

    Last year, Gatorade launched a Gx Sweat Patch paired with a smartphone app.

    The company also been conducting a pilot project on an industrial version with energy-production giant Chevron that would help companies monitor hydration and nutrition needs of workers in extreme heat and other harsh conditions. The company also has developed an FDA-approved device for clinical researchers, who find sweat collection a less-invasive way to evaluate research participants.

    Epicore, which was formed in 2017, is based in Cambridge, Mass., which also was home to other startups based on Rogers’ innovations in wearable technology. Investors include Chevron Technology Ventures, Alumni Ventures and Joyance Partners. Strategic backers and customers include Gatorade’s parent company, PepsiCo, the Air Force and Army and the National Institutes of Health.

    Roozbeh Gaffari, a longtime collaborator with Rogers and a fellow researcher at Northwestern’s Querrey Simpson Institute for Bioelectronics, is CEO. The company has about a dozen employees.

    Another Northwestern spinout based on Rogers’ technology is Rhaeos, which has raised $5 million in grants to develop a wearable sensor to monitor shunts that are implanted to drain excess fluid from the brain.

    This story first appeared in our sister publication, Crain's Chicago Business.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it online.

    Recommended for You
    AMN Stand 3.0 with Pregnant-2-Full REZ-2 (5).jpg
    Medical interpreters face high demand, low reimbursement
    Amazon RxPass
    Amazon rolls out generic drug subscription service
    Sponsored Content
    Get Newsletters

    Newsletters for providers, payers, investors and innovators across the digital health ecosystem. Sign up to get breaking digital health news including digital health deals, M&A, finance, IPOs. as they happen, right to your inbox.

    Buy Q3 Report Today
    Quarterly Report Cover Image

    The Digital Health Funding and M&A Q3 report delivers the most comprehensive insight and data around the financial health of the sector.

    Purchase Today
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Digital Health Business & Technology delivers news, data, insights and analysis covering the entire digital healthcare ecosystem.

    Logo
    Contact Us

    (877) 812-1581

    Email us

     

    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    Resources
    • About Us
    • Contact Us
    • Staff
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Digital Health Business & Technology
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • Consumer Centric
    • Provider/Payer Centric
    • Funding/M&A
    • Policy
    • Data
    • Opinion
    • MORE+
      • Webinars
      • Advertise